Allworth Financial LP Regeneron Pharmaceuticals, Inc. Transaction History

Allworth Financial LP

$15.5 Billion
Q2 2024

A detailed history of Allworth Financial LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 661 shares of REGN stock, worth $688,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares

661

Previous 528 25.19%

Holding current value

$688,854

Previous $508,000 36.61%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$883.2 - $1071.19 $117,465 - $142,468	133 Added 25.19%	661 $694,000
Q1 2024 Apr 25, 2024	BUY	$902.69 - $993.35 $149,846 - $164,896	166 Added 45.86%	528 $508,000
Q4 2023 Jan 24, 2024	BUY	$775.18 - $881.7 $3,100 - $3,526	4 Added 1.12%	362 $317,000
Q3 2023 Oct 31, 2023	BUY	$692.45 - $844.37 $11,079 - $13,509	16 Added 4.68%	358 $294,000
Q2 2023 Jul 18, 2023	BUY	$700.03 - $830.35 $125,305 - $148,632	179 Added 109.82%	342 $245,000
Q1 2023 Apr 18, 2023	BUY	$680.49 - $826.97 $16,331 - $19,847	24 Added 17.27%	163 $133,000
Q4 2022 Jan 13, 2023	BUY	$705.89 - $766.39 $7,058 - $7,663	10 Added 7.75%	139 $0
Q3 2022 Oct 18, 2022	BUY	$573.97 - $724.32 $21,236 - $26,799	37 Added 40.22%	129 $89,000
Q2 2022 Jul 13, 2022	BUY	$548.35 - $738.84 $24,675 - $33,247	45 Added 95.74%	92 $54,000
Q1 2022 Apr 22, 2022	SELL	$595.12 - $698.43 $4,760 - $5,587	-8 Reduced 14.55%	47 $33,000
Q4 2021 Jan 21, 2022	BUY	$543.48 - $670.97 $12,500 - $15,432	23 Added 71.88%	55 $35,000
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $18,368 - $21,790	32 New	32 $19,000
Q2 2021 Aug 02, 2021	SELL	$472.8 - $558.54 $17,020 - $20,107	-36 Closed	0 $0
Q2 2020 Jul 24, 2020	BUY	$493.32 - $643.92 $17,759 - $23,181	36 New	36 $22,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Account

Allworth Financial LP Regeneron Pharmaceuticals, Inc. Transaction History